Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Tempest Therapeutics, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Tempest Therapeutics is a clinical-stage biotechnology company developing cancer immunotherapy treatments. The company focuses on novel small molecule therapeutics targeting the tumor microenvironment to improve patient outcomes. Tempest is advancing multiple programs through clinical trials for various oncology indications.